Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/79768
Registro completo de metadatos
Registro completo de metadatos
Campo DCValorIdioma
dc.contributorNeurobiología del Sistema Visual y Terapia de Enfermedades Neurodegenerativas (NEUROVIS)es_ES
dc.contributor.authorOrtuño-Lizarán, Isabel-
dc.contributor.authorEsquiva, Gema-
dc.contributor.authorBeach, Thomas G.-
dc.contributor.authorSerrano, Geidy-
dc.contributor.authorAdler, Charles H.-
dc.contributor.authorLax, Pedro-
dc.contributor.authorCuenca, Nicolás-
dc.contributor.otherUniversidad de Alicante. Departamento de Fisiología, Genética y Microbiologíaes_ES
dc.date.accessioned2018-09-17T09:55:11Z-
dc.date.available2018-09-17T09:55:11Z-
dc.date.issued2018-09-10-
dc.identifier.citationActa Neuropathologica Communications. 2018, 6:90. doi:10.1186/s40478-018-0596-zes_ES
dc.identifier.issn2051-5960-
dc.identifier.urihttp://hdl.handle.net/10045/79768-
dc.description.abstractParkinson’s disease (PD) patients often suffer from non-motor symptoms like sleep dysregulation, mood disturbances or circadian rhythms dysfunction. The melanopsin-containing retinal ganglion cells are involved in the control and regulation of these processes and may be affected in PD, as other retinal and visual implications have been described in the disease. Number and morphology of human melanopsin-containing retinal ganglion cells were evaluated by immunohistochemistry in eyes from donors with PD or control. The Sholl number of intersections, the number of branches, and the number of terminals from the Sholl analysis were significantly reduced in PD melanopsin ganglion cells. Also, the density of these cells significantly decreased in PD compared to controls. Degeneration and impairment of the retinal melanopsin system may affect to sleep and circadian dysfunction reported in PD pathology, and its protection or stimulation may lead to better disease prospect and global quality of life of patients.es_ES
dc.description.sponsorshipThis work was supported by the Michael J. Fox Foundation for Parkinson’s Research. I.O.L. acknowledges financial support from the Ministerio de Educación, Spain (FPU 14/03166). N.C. acknowledges financial support from the Ministerio de Economía y Competitividad, Spain (MINECO-FEDER-BFU2015-67139-R), Generalitat Valenciana (Prometeo 2016/158), and Instituto Carlos III (ISCIII RETICS-FEDER RD16/0008/0016). The Brain and Body Donation Program has been supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026), the National Institute on Aging (P30 AG19610), the Arizona Department of Health Services, the Arizona Biomedical Research Commission, and the Michael J. Fox Foundation for Parkinson’s Research.es_ES
dc.languageenges_ES
dc.publisherBioMed Centrales_ES
dc.rights© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.es_ES
dc.subjectRetinaes_ES
dc.subjectParkinson’s diseasees_ES
dc.subjectCircadian rhythmses_ES
dc.subjectSleep disorderses_ES
dc.subjectMelanopsin retinal ganglion celles_ES
dc.subjectHumanes_ES
dc.subject.otherFisiologíaes_ES
dc.subject.otherBiología Celulares_ES
dc.titleDegeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.peerreviewedsies_ES
dc.identifier.doi10.1186/s40478-018-0596-z-
dc.relation.publisherversionhttps://doi.org/10.1186/s40478-018-0596-zes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
Aparece en las colecciones:INV - NEUROVIS - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
Thumbnail2018_Ortuno-Lizaran_etal_ActaNeuropathComm.pdf3,39 MBAdobe PDFAbrir Vista previa


Este ítem está licenciado bajo Licencia Creative Commons Creative Commons